Corbus Pharmaceuticals Holdings (CRBP) · CRB-701 + pembrolizumab
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: early 2027
anticipated data readout of CRB-701 in 1L OPSCC in early 2027
EX-99.1 · filed · SEC filing
After
Stated timing: Q1 2027
CRB-701 + pembrolizumab data in 1L OPSCC in Q1 2027
EX-99.2 · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/CRBP-crb-701-pembrolizumab-2026-09-14, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/CRBP-crb-701-pembrolizumab-2026-09-14
Corbus Pharmaceuticals Holdings (CRBP) pipeline and stated timing · Calendar · Companies A–Z